Man Group’s AC Immune ACIU Stock Holding History

Man Group’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27,361	Closed	-$103K	–	1966
2024 Q3	$103K	Buy	+27,361	New	+$95.5K	﹤0.01%	1899

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group's ACIU Position: Q4 2024 in Review

Man Group sold out of AC Immune (ACIU) in Q4 2024, closing a stake of 27,361 shares — an estimated $103K sold.

Man Group first reported a position in ACIU in Q3 2024 and held it in 1 quarter. The position peaked at $103K in Q3 2024. 45 funds tracked by Wall St. Rank hold ACIU as of Q4 2024.

Man Group reported no remaining AC Immune position as of Q4 2024 after selling out during the quarter.
Man Group sold 27,361 AC Immune shares in Q4 2024, an estimated $103K.
Man Group first reported a position in AC Immune in Q3 2024 and held it in 1 quarter.
Man Group's AC Immune position peaked at $103K in Q3 2024.
45 funds tracked by Wall St. Rank held AC Immune as of Q4 2024.

Based on Man Group's 13F filing for Q4 2024, filed 14 Feb 2025.